title: Hepatic failure during anabolic steroid therapy.
authors.affiliation: Digestive Disease Center, The Tazuke Kofukai Medical Research Institute, Kitano Hospital, Osaka, Japan.
authors.forename: Tadayuki
authors.initials: T
authors.lastname: Kou
authors.forename: Masaki
authors.initials: M
authors.lastname: Watanabe
authors.forename: Shujiro
authors.initials: S
authors.lastname: Yazumi
mesh_terms: D000368:Aged; D045930:Anabolic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003613:Danazol / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008099:Liver / Q000473:pathology / Q000503:physiopathology; D017093:Liver Failure / Q000175:diagnosis / Q000209:etiology* / Q000473:pathology; D008111:Liver Function Tests; D008279:Magnetic Resonance Imaging; D008297:Male; D010382:Peliosis Hepatis / Q000139:chemically induced* / Q000150:complications* / Q000175:diagnosis; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000188:drug therapy; D013256:Steroids / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D045930:Anabolic Agents; D013256:Steroids; D003613:Danazol